Evidence map›Paper›PMID 33797220›Full record

ArticleACS applied materials & interfaces2021

Magnetic Nanoparticle-Based Hyperthermia Mediates Drug Delivery and Impairs the Tumorigenic Capacity of Quiescent Colorectal Cancer Stem Cells.

Soraia Fernandes, Tamara Fernandez, Sabrina Metze, Preethi B Balakrishnan, Binh T Mai, John Conteh, Claudia De Mei, Alice Turdo, Simone Di Franco, Giorgio Stassi and 2 more

Open access · hybridAbstract read
In one paragraph

Article in ACS applied materials & interfaces, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
5.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 74 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Advanced drug delivery platforms target cancer stem cells.Asian journal of pharmaceutical sciences · 2025
    Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Review
  20. Eradicating the tumor "seeds": nanomedicines-based therapies against cancer stem cells.Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Soraia FernandesIstituto Italiano di Tecnologia (IIT), via Morego 30, 16163 Genova, Italy.
Tamara FernandezIstituto Italiano di Tecnologia (IIT), via Morego 30, 16163 Genova, Italy.
Sabrina MetzeIstituto Italiano di Tecnologia (IIT), via Morego 30, 16163 Genova, Italy.
Preethi B BalakrishnanIstituto Italiano di Tecnologia (IIT), via Morego 30, 16163 Genova, Italy.
Binh T MaiIstituto Italiano di Tecnologia (IIT), via Morego 30, 16163 Genova, Italy.ORCID http://orcid.org/0000-0002-3418-0658
John ContehIstituto Italiano di Tecnologia (IIT), via Morego 30, 16163 Genova, Italy.
Claudia De MeiIstituto Italiano di Tecnologia (IIT), via Morego 30, 16163 Genova, Italy.
Alice TurdoPROMISE Department,Piazza delle Cliniche 2, University of Palermo, 90133 Palermo, Italy.
Simone Di FrancoDICHIRONS Department, University of Palermo, Via del Vespro 129, 90133 Palermo, Italy.
Giorgio StassiDICHIRONS Department, University of Palermo, Via del Vespro 129, 90133 Palermo, Italy.
Matilde TodaroPROMISE Department,Piazza delle Cliniche 2, University of Palermo, 90133 Palermo, Italy.
Teresa PellegrinoIstituto Italiano di Tecnologia (IIT), via Morego 30, 16163 Genova, Italy.ORCID http://orcid.org/0000-0001-5518-1134
Italian Institute of Technology · ITUniversity of Palermo · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cancer stem cells (CSCs) are the tumor cell subpopulation responsible for resistance to chemotherapy, tumor recurrence, and metastasis. An efficient therapy must act on low proliferating quiescent-CSCs (q-CSCs). We here investigate the effect of magnetic hyperthermia (MHT) in combination with local chemotherapy as a dual therapy to inhibit patient-derived colorectal qCR-CSCs. We apply iron oxide nanocubes as MHT heat mediators, coated with a thermoresponsive polymer (TR-Cubes) and loaded with DOXO (TR-DOXO) as a chemotherapeutic agent. The thermoresponsive polymer releases DOXO only at a temperature above 44 °C. In colony-forming assays, the cells exposed to TR-Cubes with MHT reveal that qCR-CSCs struggle to survive the heat damage and, with a due delay, restart the division of dormant cells. The eradication of qCR-CSCs with a complete stop of the colony formation was achieved only with TR-DOXO when exposed to MHT. The

Indexed as

Drug Delivery SystemsHyperthermia, InducedAntibiotics, AntineoplasticColorectal NeoplasmsCombined Modality TherapyDoxorubicinHumansMagnetite NanoparticlesNeoplastic Stem CellsAntibiotics, AntineoplasticDoxorubicinMagnetite Nanoparticlescancer stem cellscolorectal cancerdoxorubicinmagnetic hyperthermiamagnetic nanoparticles

Identifiers

PMID33797220
PMCPMC8045020
OpenAlexW3145769422

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.